We can distinguish between different groups of BC according to the molecular profile as those that express Estrogen Receptor (ER) and/or Progesterone Receptor (PR) (75%), those that express Epidermal Growth Factor Receptor 2 (Her2) (15%) [2], and tumors that do not express any of these three markers, the triple-negative (TN) tumors (10–20%) [3]. Here, ERBB2 is linked to breast cancer.